Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Genetic Factors Influencing the Factor VIII Response to Desmopressin in Carriers of Hemophilia A: the GIDEHAC Study

NCT06020456 is registered in ClinicalTrials.gov with Groupe Maladies hémorragiques de Bretagne as lead sponsor.

NCT NCT06020456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06020456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Genetic Factors Influencing the Factor VIII Response to Desmopressin in Carriers of Hemophilia A: the GIDEHAC Study
Lead sponsor
Groupe Maladies hémorragiques de Bretagne
Phase
Observational
Overall status
Completed
Start date
January 1, 2022
Completion date
April 1, 2023
Enrollment
361 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

carrier of hemophilia a, desmopressin, factor viii deficiency